PlainPharmaWatch

CMS Open Payments · Program Year 2024

Avvisto Therapeutics, LLC

Avvisto Therapeutics, LLC reported $8,858.89 in payments to 478 physicians and teaching hospitals across 478 transactions.

See the rankings → How this is sourced
$8.9K
Total payments
478
Transactions
478
Recipients
#1655
of 1,925 companies

Avvisto Therapeutics, LLC reported $8,858.89 in payments to 478 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #1655 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $18.53 per recipient across 1 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

Avvisto Therapeutics, LLC pairs modest payment volume with an unusually diversified payment pattern across a wide recipient base.

#1655
of 1,925 companies
0.0%
of all US industry payments
0.0%
paid to its single top recipient
1
payment categories

How Avvisto Therapeutics, LLC ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Avvisto Therapeutics, LLC's total vs. every reporting company

CMS Open Payments, Program Year 2024

$8,859 14th percentile higher than 14% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). This entry sits in this band. $25,112–$78,003: 249 reporting companies (13%). Above this entry. $78,003–$242,294: 295 reporting companies (15%). Above this entry. $242,294–$752,621: 270 reporting companies (14%). Above this entry. $752,621–$2,337,813: 263 reporting companies (14%). Above this entry. $2,337,813–$7,261,783: 200 reporting companies (10%). Above this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Avvisto Therapeutics, LLC

Rank #1655 of 1,925 companies in CMS Open Payments for 2024 belongs to Avvisto Therapeutics, LLC, which reported $8,858.89 across 478 transactions to 478 recipients - a comparatively small 0.0% slice of all industry payments reported nationwide for the year. Averages work out to $18.53 per transaction and $18.53 per recipient.

478 transactions worth $8.9K make "Food and Beverage" the top general-payment category in the 1-category breakdown below, 100.0% of the reported total (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

"Food and Beverage" leads Avvisto Therapeutics, LLC's 1-category general-payment breakdown at $8.9K, 100.0% of the reported total.

How Avvisto Therapeutics, LLC divides its payments

Top payment categories by total reported dollar volume

1. Food and Beverage$8.9K
Payment Type Amount Transactions
Food and Beverage $8.9K 478

Recipient Concentration in General Payments

The five largest recipient relationships account for $553.94 (6.3%) of $8,858.89 in this company's General Payments records across 297 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Avvisto Therapeutics, LLC

The five named recipients with the highest reported General Payments from this company

Laura S Dankovich$118.55David Walker$118.55Eric R Serrano$114.52Daryana Aronova$110.24Stella Ilyayeva$92.08
  1. 1

    Laura S Dankovich

    $118.55 across 2 reported transactions

  2. 2

    David Walker

    $118.55 across 2 reported transactions

  3. 3

    Eric R Serrano

    $114.52 across 3 reported transactions

  4. 4

    Daryana Aronova

    $110.24 across 6 reported transactions

  5. 5

    Stella Ilyayeva

    $92.08 across 5 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $18.53. Average per recipient: $18.53.

Total Amount

$8,858.89

Avg per Transaction

$18.53

Avg per Recipient

$18.53

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Avvisto Therapeutics, LLC Share

0.0%

#1655 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to Avvisto Therapeutics, LLC

Auxano Medical LLC

$8.8K 10 recipients

Digestive Care, Inc.

$9.0K 333 recipients

Biocartis US, Inc

$9.2K 16 recipients

Prolaio, Inc.

$8.5K 15 recipients

G21 Srl

$9.2K 9 recipients

Darco International, Inc.

$8.5K 6 recipients

Frequently Asked Questions

How much did Avvisto Therapeutics, LLC pay to physicians and hospitals in 2024? ▾
In Program Year 2024, CMS Open Payments recorded $8,858.89 from Avvisto Therapeutics, LLC to physicians and hospitals across 478 transactions - 0.0% of all industry payments reported that year.
How many physicians received payments from Avvisto Therapeutics, LLC? ▾
Avvisto Therapeutics, LLC made payments to 478 physicians and teaching hospitals in 2024. The average payment per recipient was $18.53.
What types of payments did Avvisto Therapeutics, LLC make? ▾
General payments from Avvisto Therapeutics, LLC span 1 distinct categories, covering things like consulting, meals, and travel. The largest general-payment category was "Food and Beverage" at $8.9K, representing 100.0% of the company's reported total.
How does Avvisto Therapeutics, LLC rank among pharmaceutical companies? ▾
Avvisto Therapeutics, LLC ranks #1655 out of 1,925 companies by total payment amount in the CMS Open Payments database for 2024.
What is the average payment size from Avvisto Therapeutics, LLC? ▾
Avvisto Therapeutics, LLC's 478 transactions to 478 recipients in 2024 averaged $18.53 per transaction.
Where does the payment data for Avvisto Therapeutics, LLC come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Avvisto Therapeutics, LLC's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.